Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly
Pediatric Blood & Cancer · 2023-09 · 70 (9)
DOI: 10.1002/pbc.30419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 17.05.2023. Verfasst von Jeremy M Grenier und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Intramural NIH HHS, NIH HHS.
Abstract (Originalsprache)
Complex lymphatic anomalies are debilitating conditions characterized by aberrant development of the lymphatic vasculature (lymphangiogenesis). Diagnosis is typically made by history, examination, radiology, and histologic findings. However, there is significant overlap between conditions, making accurate diagnosis difficult. Recently, genetic analysis has been offered as an additional diagnostic modality. Here, we describe four cases of complex lymphatic anomalies, all with PIK3CA variants but with varying clinical phenotypes. Identification of PIK3CA resulted in transition to a targeted inhibitor, alpelisib. These cases highlight the genetic overlap between phenotypically diverse lymphatic anomalies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Comprehensive Vascular Anomaly Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Unit on Vascular Malformations, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
- Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Jeremy M Grenier, Alexandra J Borst, Kristen M Snyder, Abhay S Srinivasan
Förderung
- NCATS NIH HHS
- Intramural NIH HHS
- NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institutes of Health
Zitieren
APA
Grenier, J. M., Borst, A. J., Sheppard, S. E., Snyder, K. M., Li, D., Surrey, L. F., Al-Ibraheemi, A., Weber, D. R., Treat, J. R., Smith, C. L., Laje, P., Dori, Y., Adams, D. M., Acord, M., & Srinivasan, A. S. (2023). Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly. Pediatric Blood & Cancer, 70(9). https://doi.org/10.1002/pbc.30419
Vancouver
Grenier JM, Borst AJ, Sheppard SE, Snyder KM, Li D, Surrey LF, et al. Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly. Pediatric Blood & Cancer. 2023;70(9). doi:10.1002/pbc.30419
BibTeX
@article{Grenier2023,
author = {Grenier, Jeremy M and Borst, Alexandra J and Sheppard, Sarah E and Snyder, Kristen M and Li, Dong and Surrey, Lea F and Al-Ibraheemi, Alyaa and Weber, David R and Treat, James R and Smith, Christopher L and Laje, Pablo and Dori, Yoav and Adams, Denise M and Acord, Michael and Srinivasan, Abhay S},
title = {Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly},
journal = {Pediatric Blood & Cancer},
year = {2023},
volume = {70},
number = {9},
doi = {10.1002/pbc.30419}
}
EUVIMED